As the US sees its highest number of measles cases in decades and vaccination rates fall, researchers are developing drugs to ...

Rabies is one of the deadliest infectious diseases, but it is also preventable when treated quickly after an animal bite. A new post-licensure clinical study published in The Lancet further ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven have ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven have ...

The exact mechanism responsible for infusion-related reactions (IRRs) after monoclonal antibody (mAb) therapy is unclear. It is also unknown before treatment which patient will develop IRRs. The ...

Researchers in Switzerland have conducted the first systematic study that demonstrated that even small variations in a person’s genome can disrupt the therapeutic effects of monoclonal antibodies. “We ...

Patients with moderate to severe acute respiratory distress syndrome receiving a monoclonal antibody treatment vs. placebo ...

Scientists find immune markers that may catch Lyme disease earlier and explain why some patients' symptoms linger.